145 related articles for article (PubMed ID: 17676726)
1. Synthesis of specific bivalent probes that functionally interact with 5-HT(4) receptor dimers.
Russo O; Berthouze M; Giner M; Soulier JL; Rivail L; Sicsic S; Lezoualc'h F; Jockers R; Berque-Bestel I
J Med Chem; 2007 Sep; 50(18):4482-92. PubMed ID: 17676726
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of specific probes for human 5-HT4 receptor dimerization studies.
Soulier JL; Russo O; Giner M; Rivail L; Berthouze M; Ongeri S; Maigret B; Fischmeister R; Lezoualc'h F; Sicsic S; Berque-Bestel I
J Med Chem; 2005 Oct; 48(20):6220-8. PubMed ID: 16190749
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease.
Russo O; Cachard-Chastel M; Rivière C; Giner M; Soulier JL; Berthouze M; Richard T; Monti JP; Sicsic S; Lezoualc'h F; Berque-Bestel I
J Med Chem; 2009 Apr; 52(8):2214-25. PubMed ID: 19334715
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.
Berque-Bestel I; Soulier JL; Giner M; Rivail L; Langlois M; Sicsic S
J Med Chem; 2003 Jun; 46(13):2606-20. PubMed ID: 12801225
[TBL] [Abstract][Full Text] [Related]
5. Two transmembrane Cys residues are involved in 5-HT4 receptor dimerization.
Berthouze M; Rivail L; Lucas A; Ayoub MA; Russo O; Sicsic S; Fischmeister R; Berque-Bestel I; Jockers R; Lezoualc'h F
Biochem Biophys Res Commun; 2007 May; 356(3):642-7. PubMed ID: 17379184
[TBL] [Abstract][Full Text] [Related]
6. Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
Choi SK; Green D; Ho A; Klein U; Marquess D; Taylor R; Turner SD
J Med Chem; 2008 Jun; 51(12):3609-16. PubMed ID: 18507369
[TBL] [Abstract][Full Text] [Related]
7. Bivalent dopamine D2 receptor ligands: synthesis and binding properties.
Kühhorn J; Hübner H; Gmeiner P
J Med Chem; 2011 Jul; 54(13):4896-903. PubMed ID: 21599022
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
[TBL] [Abstract][Full Text] [Related]
10. Bivalent argininamide-type neuropeptide y y(1) antagonists do not support the hypothesis of receptor dimerisation.
Keller M; Teng S; Bernhardt G; Buschauer A
ChemMedChem; 2009 Oct; 4(10):1733-45. PubMed ID: 19672917
[TBL] [Abstract][Full Text] [Related]
11. Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors.
Leopoldo M; Lacivita E; Colabufo NA; Niso M; Berardi F; Perrone R
Bioorg Med Chem; 2007 Aug; 15(15):5316-21. PubMed ID: 17517509
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.
Siracusa MA; Salerno L; Modica MN; Pittalà V; Romeo G; Amato ME; Nowak M; Bojarski AJ; Mereghetti I; Cagnotto A; Mennini T
J Med Chem; 2008 Aug; 51(15):4529-38. PubMed ID: 18598015
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.
Tejada FR; Nagy PI; Xu M; Wu C; Katz T; Dorsey J; Rieman M; Lawlor E; Warrier M; Messer WS
J Med Chem; 2006 Dec; 49(25):7518-31. PubMed ID: 17149881
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and receptor binding of new thieno[2,3-d]-pyrimidines as selective ligands of 5-HT(3) receptors.
Modica MN; Romeo G; Salerno L; Pittalà V; Siracusa MA; Mereghetti I; Cagnotto A; Mennini T; Gáspár R; Gál A; Falkay G; Palkó M; Maksay G; Fülöp F
Arch Pharm (Weinheim); 2008 Jun; 341(6):333-43. PubMed ID: 18535994
[TBL] [Abstract][Full Text] [Related]
15. Development of a bivalent dopamine D₂ receptor agonist.
Kühhorn J; Götz A; Hübner H; Thompson D; Whistler J; Gmeiner P
J Med Chem; 2011 Nov; 54(22):7911-9. PubMed ID: 21999579
[TBL] [Abstract][Full Text] [Related]
16. Multivalent-based drug design applied to serotonin 5-HT(4) receptor oligomers.
Lezoualc'h F; Jockers R; Berque-Bestel I
Curr Pharm Des; 2009; 15(6):719-29. PubMed ID: 19199991
[TBL] [Abstract][Full Text] [Related]
17. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.
Łazewska D; Kuder K; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
Bioorg Med Chem; 2008 Sep; 16(18):8729-36. PubMed ID: 18774720
[TBL] [Abstract][Full Text] [Related]
18. Conformational toggle switches implicated in basal constitutive and agonist-induced activated states of 5-hydroxytryptamine-4 receptors.
Pellissier LP; Sallander J; Campillo M; Gaven F; Queffeulou E; Pillot M; Dumuis A; Claeysen S; Bockaert J; Pardo L
Mol Pharmacol; 2009 Apr; 75(4):982-90. PubMed ID: 19168624
[TBL] [Abstract][Full Text] [Related]
19. Constitutive dimerization of human serotonin 5-HT4 receptors in living cells.
Berthouze M; Ayoub M; Russo O; Rivail L; Sicsic S; Fischmeister R; Berque-Bestel I; Jockers R; Lezoualc'h F
FEBS Lett; 2005 Jun; 579(14):2973-80. PubMed ID: 15896782
[TBL] [Abstract][Full Text] [Related]
20. New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket.
Rivail L; Giner M; Gastineau M; Berthouze M; Soulier JL; Fischmeister R; Lezoualc'h F; Maigret B; Sicsic S; Berque-Bestel I
Br J Pharmacol; 2004 Oct; 143(3):361-70. PubMed ID: 15351779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
